Agonist-antagonist properties of N-allyl-[D-Ala]2-Met-enkephalin.
D000698:Analgesia; D000818:Animals; D001667:Binding, Competitive / Q000187:drug effects; D004745:Enkephalins / Q000378:metabolism*; D006801:Humans; D009842:Oligopeptides / Q000378:metabolism*; D051381:Rats; D011957:Receptors, Opioid / Q000378:metabolism*; D012964:Sodium / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D013375:Substance Withdrawal Syndrome / Q000139:chemically induced; D008083:beta-Lipotropin / Q000378:metabolism
D004745:Enkephalins; D009842:Oligopeptides; D011957:Receptors, Opioid; D008083:beta-Lipotropin; D012964:Sodium